Long term beta-adrenergic blockade reduces tyrosine hydroxylase and dopamine beta-hydroxylase activities in sympathetic ganglia.
about
Cardiac adrenergic control and atrial fibrillation.The effect of chronic oxprenolol therapy on blood prolactin, growth hormone, renin and aldosterone levels.Adaptation of hypertensives to treatment with cardioselective and non-selective beta-blockers. Absence of correlation between bradycardia and blood pressure control, and reduction in slope of the QT/RR relation.Prevention and reversal of isolation-induced systolic arterial hypertension in rats by treatment with beta-adrenoceptor antagonists.Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol.The mechanisms of antihypertensive action of beta-adrenergic receptor blocking drugs.Effect of metoprolol on 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension.Influence of beta-adrenoceptor blocking agents on the turnover rate of cardiac and splenic noradrenaline in rats.Effect of prolonged beta-adrenoceptor blockade on heart weight and ultrastructure in young rabbits.How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.Adrenal hormone deprivation affects macrophage catecholamine metabolism and β2-adrenoceptor density, but not propranolol stimulation of tumour necrosis factor-α production.Migraine and beta-blockade: modulation of sympathetic neurotransmission.Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade.
P2860
Q33792556-69739283-8589-4336-B583-B434B298ADC9Q34518131-E2E95933-6F85-4D4D-AE38-54C344DA20F9Q36776487-133460BE-2E35-4493-9C68-3AD4A2040194Q39232332-016BD8E0-A0C1-43FF-9860-44049D90BD35Q41202215-44495DE1-5379-4C70-90EB-97B8C2B53062Q41465541-80B198F5-D4AF-499B-A5F2-CF3CE7563B28Q41747232-576BDB4A-81EB-40CB-BDA7-F2773463BF93Q42632236-C47F33D8-CD7C-4103-AEFE-43B1154F4568Q42632278-3F178786-A5E7-4ADE-AE7A-DE3BA8CD8680Q42705000-1EB6E063-8DB3-4352-B598-389C60DB2CB8Q45896730-195EB13F-280F-4B53-B4F6-39810F7CEEA7Q46324468-6AAECA03-F866-40DF-ABF9-12ABD2A3AD1AQ55365668-0F8A6436-E9C4-4956-AB91-7412B26CC4E2
P2860
Long term beta-adrenergic blockade reduces tyrosine hydroxylase and dopamine beta-hydroxylase activities in sympathetic ganglia.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Long term beta-adrenergic bloc ...... vities in sympathetic ganglia.
@en
Long term beta-adrenergic bloc ...... vities in sympathetic ganglia.
@nl
type
label
Long term beta-adrenergic bloc ...... vities in sympathetic ganglia.
@en
Long term beta-adrenergic bloc ...... vities in sympathetic ganglia.
@nl
prefLabel
Long term beta-adrenergic bloc ...... vities in sympathetic ganglia.
@en
Long term beta-adrenergic bloc ...... vities in sympathetic ganglia.
@nl
P2860
P356
P1433
P1476
Long term beta-adrenergic bloc ...... vities in sympathetic ganglia.
@en
P2093
P2860
P2888
P304
P356
10.1038/267265A0
P407
P577
1977-05-01T00:00:00Z
P6179
1035516967